Share Buyback Program: DKK20 billion concluded. Novo Nordisk AS (NYSE:NVO) reported a strong 26% sales growth and 26% operating profit growth for 2024. The company expanded its patient reach ...

The most recent Pod 4 Ultra is currently $150 off all sizes at Eight Sleep. Aimed at hot sleepers and those who want to understand what happens within their sleeping body, the Eight Sleep Pod 4 ...

Phase 3 results reported for CagriSema last month were a disappointment, however, with a 20.4% reduction in weight in the REDEFINE 1 study over 68 weeks that fell short of Novo Nordisk's hope of a ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

News, views and features on today's stories in Parliament ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Use left and right arrow keys to scroll through schedule ...

After hours: 7:59:22 p.m. EST Loading Chart for NVO ...